-
1
المؤلفون: Paul J. Hengeveld, Y. Emre Ertem, Julie M. N. Dubois, Clemens H. M. Mellink, Anne-Marie van der Kevie-Kersemaekers, Ludo M. Evers, Kim Heezen, P. Martijn Kolijn, Olaf R. F. Mook, M. Mahdi Motazacker, Kazem Nasserinejad, S. Kersting, Peter E. Westerweel, Carsten U. Niemann, Arnon P. Kater, Anton W. Langerak, Mark-David Levin
المساهمون: Immunology, Hematology, Human Genetics, ARD - Amsterdam Reproduction and Development, ACS - Pulmonary hypertension & thrombosis, ANS - Complex Trait Genetics, CCA - Cancer biology and immunology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life
المصدر: Leukemia, 36(7), 1935-1938. Nature Publishing Group
Hengeveld, P J, Ertem, Y E, Dubois, J M N, Mellink, C H M, van der Kevie-Kersemaekers, A-M, Evers, L M, Heezen, K, Kolijn, P M, Mook, O R F, Motazacker, M M, Nasserinejad, K, Kersting, S, Westerweel, P E, Niemann, C U, Kater, A P, Langerak, A W & Levin, M-D 2022, ' Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110 ', Leukemia, vol. 36, no. 7, pp. 1935-1938 . https://doi.org/10.1038/s41375-022-01600-6مصطلحات موضوعية: Cancer Research, Oncology, SDG 3 - Good Health and Well-being, Hematology
وصف الملف: application/pdf
-
2
المؤلفون: Arnon P Kater, Mark-David Levin, Julie Dubois, Sabina Kersting, Lisbeth Enggaard, Gerrit J Veldhuis, Rogier Mous, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Johan A Dobber, Christian B Poulsen, Henrik Frederiksen, Ann Janssens, Ida Schjødt, Ellen C Dompeling, Juha Ranti, Christian Brieghel, Mattias Mattsson, Mar Bellido, Hoa T T Tran, Kazem Nasserinejad, Carsten U Niemann
المساهمون: Hematology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Human Genetics, ARD - Amsterdam Reproduction and Development
المصدر: The Lancet Oncology, 23(6), 818-828. Lancet Publishing Group
Kater, A P, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, van der Kevie-Kersemaekers, A-M F, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Brieghel, C, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Niemann, C U 2022, ' Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION) : primary analysis of an open-label, randomised, phase 2 trial ', The Lancet Oncology, vol. 23, no. 6, pp. 818-828 . https://doi.org/10.1016/S1470-2045(22)00220-0
Lancet Oncology, 23(6), 818-828. ELSEVIER SCIENCE INC
The Lancet. Oncology, 23(6), 818-828. Lancet Publishing Groupمصطلحات موضوعية: Sulfonamides, BCL2, Neoplasm, Residual, Adenine, PROLIFERATION, MULTICENTER, Bridged Bicyclo Compounds, Heterocyclic, BCR, Leukemia, Lymphocytic, Chronic, B-Cell, 1ST-LINE TREATMENT, Pyrimidines, Piperidines, Oncology, Antineoplastic Combined Chemotherapy Protocols, CYCLOPHOSPHAMIDE, CELLS, Humans, Pyrazoles, RITUXIMAB, FLUDARABINE, CLL
وصف الملف: application/pdf
-
3
المؤلفون: Paul J, Hengeveld, Y Emre, Ertem, Julie M N, Dubois, Clemens H M, Mellink, Anne-Marie, van der Kevie-Kersemaekers, Ludo M, Evers, Kim, Heezen, P Martijn, Kolijn, Olaf R F, Mook, M Mahdi, Motazacker, Kazem, Nasserinejad, S, Kersting, Peter E, Westerweel, Carsten U, Niemann, Arnon P, Kater, Anton W, Langerak, Mark-David, Levin
المصدر: Leukemia. 36(7)
مصطلحات موضوعية: Treatment Outcome, Immunoglobulin Variable Region, Humans, Immunoglobulin Heavy Chains, Leukemia, Lymphocytic, Chronic, B-Cell